Page last updated: 2024-10-29

ketamine and Brain Hemorrhage

ketamine has been researched along with Brain Hemorrhage in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Welling, L1
Welling, MS1
Teixeira, MJ1
Figueiredo, EG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
S-ketamine for Cortical Spreading Depolarisation in Patients With Severe Acute Brain Injury[NCT05095857]Phase 4400 participants (Anticipated)Interventional2023-09-15Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for ketamine and Brain Hemorrhage

ArticleYear
Cortical spread depolarization and ketamine: a revival of an old drug or a new era of neuroprotective drugs?
    World neurosurgery, 2015, Volume: 83, Issue:4

    Topics: Brain Ischemia; Cerebrovascular Circulation; Cortical Spreading Depression; Humans; Intracranial Hem

2015